Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Enzyme replacement therapy developed for MPS IIID

Oct. 16, 2015

Karolinska Institutet coordinates study of stem cells in unborn babies with osteogenesis imperfecta

Oct. 16, 2015

Once-weekly growth hormone NN-8640 shows promise in phase I trial

Oct. 16, 2015

Ultragenyx reports interim data from phase II study of UX-007

Oct. 16, 2015

Synjardy now available in U.S. pharmacies

Oct. 15, 2015

NPSP-795 shows promise for ADH1

Oct. 15, 2015

Preclinical data on VS-105's effect on BMD

Oct. 15, 2015

Development of Lilly's evacetrapib terminated due to insufficient efficacy

Oct. 13, 2015

IGF-I and insulin may promote pancreatic cancer

Oct. 13, 2015

City of Hope receives NIDDK grant to study epigenetic changes in diabetes

Oct. 9, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...